Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasms. Found 243 abstracts

no pagination
Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019 Jul 16;51(1):27-41.   PMCID: PMC6831096
Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DP, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. The New England journal of medicine. 2018 Feb 22;378(8):731-9.   PMCID: PMC5857389
Golemis EA, Scheet P, Beck TN, Scolnick EM, Hunter DJ, Hawk E, Hopkins N. Molecular mechanisms of the preventable causes of cancer in the United States. Genes & development. 2018 Jul;32(13-14):868-902.   PMCID: PMC6075032
Gomez K, Miura S, Huuki LA, Spell BS, Townsend JP, Kumar S. Somatic evolutionary timings of driver mutations. BMC cancer. 2018 Jan 18;18(1):85.   PMCID: PMC5774140
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2018 Jun;21(6):742-7.
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value Health. 2018 Jun;21(6):742-7.
Lyu Z, Kang L, Buuh ZY, Jiang D, McGuth JC, Du J, Wissler HL, Cai W, Wang RE. A Switchable Site-Specific Antibody Conjugate. ACS chemical biology. 2018 Apr 20;13(4):958-64.   PMCID: PMC5910183
Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. 2018 Oct 04;175(2):416-428e13.   PMCID: PMC6482006
Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017 Oct 24;117(11):1583-91.   PMCID: PMC5729447
Dmitrieva O, Grivennikov SI. Microbiota and cancer: a complex equation with a lot of exciting unknowns. Seminars in immunology. 2017 Aug;32:1-2.   PMCID: Editorial
Dotan E. Advancing Treatment Approach to the Older Patient with Cancer Through Clinical Trials Participation. Surg Oncol Clin N Am. 2017 Oct;26(4):719-28.
Fu H, Vadalia N, Xue ER, Johnson C, Wang L, Yang WY, Sanchez C, Nelson J, Chen Q, Choi ET, Ma JX, Yu J, Wang H, Yang X. Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study. Journal of hematology & oncology. 2017 Mar 23;10(1):74.   PMCID: PMC5364721
Good CR, Madzo J, Patel B, Maegawa S, Engel N, Jelinek J, Issa JJ. A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer. Nucleic acids research. 2017 Aug 21;45(14):8269-81.   PMCID: PMC5737541
Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol. 2017 Jul;3(7):961-8.   PMCID: PMC5557289
Nieborowska-Skorska M, Maifrede S, Dasgupta Y, Sullivan K, Flis S, Le BV, Solecka M, Belyaeva EA, Kubovcakova L, Nawrocki M, Kirschner M, Zhao H, Prchal JT, Piwocka K, Moliterno AR, Wasik M, Koschmieder S, Green TR, Skoda RC, Skorski T. Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. Blood. 2017 Dec 28;130(26):2848-59.   PMCID: PMC5746670
Papadopoulos KP, Gluck L, Martin LP, Olszanski AJ, Tolcher AW, Ngarmchamnanrith G, Rasmussen E, Amore BM, Nagorsen D, Hill JS, Stephenson J. First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Oct;23(19):5703-10.
Sato T, Issa JJ, Kropf P. DNA Hypomethylating Drugs in Cancer Therapy. Cold Spring Harbor perspectives in medicine. 2017 May;7(5).   PMCID: PMC5411681
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017 Jul;58:70-6.   PMCID: Review
Aelion CM, Airhihenbuwa CO, Alemagno S, Amler RW, Arnett DK, Balas A, Bertozzi S, Blakely CH, Boerwinkle E, Brandt-Rauf P, Buekens PM, Chandler GT, Chang RW, Clark JE, Cleary PD, Curran JW, Curry SJ, Diez Roux AV, Dittus R, Ellerbeck EF, El-Mohandes A, Eriksen MP, Erwin PC, Evans G, Finnegan JR, Fried LP, Frumkin H, Galea S, Goff DC, Goldman LR, Guilarte TR, Rivera-Gutierrez R, Halverson PK, Hand GA, Harris CM, Healton CG, Hennig N, Heymann J, Hunter D, Hwang W, Jones RM, Klag MJ, Klesges LM, Lahey T, Lawlor EF, Maddock J, Martin WJ, Mazzaschi AJ, Michael M, Mohammed SD, Nasca PC, Nash D, Ogunseitan OA, Perez RA, Perri M, Petersen DJ, Peterson DV, Philbert M, Pinto-Martin J, Raczynski JM, Raskob GE, Rimer BK, Rohrbach LA, Rudkin LL, Siminoff L, Szapocznik J, Thombs D, Torabi MR, Weiler RM, Wetle TF, Williams PL, Wykoff R, Ying J. The US Cancer Moonshot initiative. Lancet Oncol. 2016 May;17(5):e178-80.   PMCID: Letter
Alexander J, Cukierman E. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. Current opinion in cell biology. 2016 Oct;42:80-93.   PMCID: PMC5064819
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasms

Neoplasms genetics therapy immunology drug therapy pathology therapeutic use Tumor Microenvironment adverse effects United States Antineoplastic Agents Pathologic Neovascularization Drug-Related Side Effects and Adverse Reactions Male Aged Medical Oncology Carcinogenesis Treatment Outcome etiology 80 and over Aged drug effects metabolism physiopathology Homeostasis Critical Pathways Mutation United States Food and Drug Administration Monoclonal Antibodies Cell Line Surveys and Questionnaires Pro-ctcae cancer Mice oncology Age Factors Binding Sites analogs & derivatives antagonists & inhibitors tolerability drug safety Middle Aged Female Inflammation chemistry diagnosis Pyrazoles Patient Reported Outcome Measures patient-reported outcomes Clinical trials Thrombosis Clonal Evolution Calreticulin Protein Kinases Pyrimidines Infections Elderly Physiologic Neovascularization Kaplan-Meier Estimate Wound Healing immunotherapy tumor evolution Receptor Protein-Tyrosine Kinases Immune-related adverse events Macrophage Colony-Stimulating Factor Proto-Oncogene Proteins diagnostic imaging antagonists & HeLa Cells Immunologic Factors Exercise Therapy Neoplastic Stem Cells Data Mining Melanoma Maximum Tolerated Dose DNA Methylation Fatigue Adult Thrombopoietin Receptors early detection epidemiology Older cancer patients Glucocorticoids Western Blotting CD4-Positive T-Lymphocytes Extracellular Matrix Mhc-ii Disease Progression blood Interleukin-1 Dextroamphetamine Fibroblasts Autoimmunity microbiology Acute Coronary Syndrome Switch Genes DNA Repair Leukocytes Preschool Child CD8-Positive T-Lymphocytes Nivolumab Somatic mutation Infant Early Detection of Cancer Genetic Heterogeneity Microbiota Transcriptome CTLA-4 Antigen Cell Transdifferentiation Clinical Trials as Topic Aging Piperazines cancer prevention Young Adult Molecular Evolution Biological Models DNA Demethylation cell plasticity Histocompatibility Antigens Class I Primary Prevention Protein Isoforms methods Embryonic Stem Cells Neoplastic Gene Expression Regulation Phthalazines HEK293 Cells Thyroiditis Myeloproliferative Disorders Antineoplastic Antimetabolites immune editing Heterografts Adolescent Cultured Tumor Cells Cancer-Associated Fibroblasts CpG Islands Serotonin Uptake Inhibitors tumor microenvironment Geriatrics Angiogenic genes cytokine Phenylalanine Peptides Antineoplastic Combined Chemotherapy Protocols tumor progression Methylphenidate Endothelial Cells Biomedical Research DNA Sequence Analysis Histocompatibility Antigens Class II Biomarkers chemically induced
Last updated on Friday, January 03, 2020